Glad to hear of this interview. In fairness I gotta say that LDN does not 100% stop MS, at least it didn't for me. I've been on it several years now, and still had a few new lesions and 1 relapse.

Its hard to know if I did better with LDN than I would without it, but clearly it doesn't completely keep it at bay.

I do hope they get real trials going with time series MRI to prove it one way or the other, but given the size of the clinical trial pipeline for MS I kinda doubt that anybody will pony up the money for LDN unless somehow a patentable derivative can be produced.